CRISPR screens of tumor-infiltrating NK cells identify genetic checkpoints for CAR-NK therapy

被引：0
|
作者：
Peng, Lei [1 ]
Chen, Sidi [1 ]
机构：
[1] Yale Univ, New Haven, CT 06520 USA
来源：
NATURE BIOTECHNOLOGY | 2024年
关键词：
D O I：
10.1038/s41587-024-02319-8
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
We use a CRISPR screening platform based on adeno-associated virus and the Sleeping Beauty transposon (AAV-SB-CRISPR) to perform in vivo CRISPR screens in primary natural killer (NK) cells across four different tumor models, and identify calcium homeostasis modulator family member 2 (CALHM2) as an NK cellular checkpoint protein.
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CAR-NK cells for cancer immunotherapy: from bench to bedside
    Leisheng Zhang
    Yuan Meng
    Xiaoming Feng
    Zhongchao Han
    Biomarker Research, 10
  • [42] Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells
    Yang, Ying
    Neo, Shi Yong
    Chen, Ziqing
    Cui, Weiyingqi
    Chen, Yi
    Guo, Min
    Wang, Yongfang
    Xu, Haiyan
    Kurzay, Annina
    Alici, Evren
    Holmgren, Lars
    Haglund, Felix
    Wang, Kai
    Lundqvist, Andreas
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (10): : 5508 - 5522
  • [43] CAR-NK cells generated with CAR-RNA-LNP express high cytotoxic activity against tumor cells
    Golubovskaya, Vita M.
    Sun, Jinying
    Sienkiewicz, John
    Huang, Yanwei
    Zhou, Hua
    Deng, Gongping
    Harto, Hizkia
    Xu, Shirley
    Berahovich, Robert
    Wu, Lijun
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Nonviral technologies can pave the way for CAR-NK cell therapy
    Bexte, Tobias
    Reindl, Lisa Marie
    Ullrich, Evelyn
    JOURNAL OF LEUKOCYTE BIOLOGY, 2023, 114 (05) : 475 - 486
  • [45] CAR-NK cell therapy in AML: Current treatment, challenges, and advantage
    Bahramloo, Mohammadmahdi
    Shahabi, Sina Alinejad
    Kalarestaghi, Hossein
    Rafat, Ali
    Mazloumi, Zeinab
    Samimifar, Arian
    Asl, Khadijeh Dizaji
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [46] CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo
    Golubovskaya, Vita
    Sienkiewicz, John
    Sun, Jinying
    Zhang, Shiming
    Huang, Yanwei
    Zhou, Hua
    Harto, Hizkia
    Xu, Shirley
    Berahovich, Robert
    Wu, Lijun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [47] Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment
    Liu, Jingfeng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [48] CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
    Li, Wangshu
    Wang, Xiuying
    Zhang, Xu
    Aziz, Aziz ur Rehman
    Wang, Daqing
    BIOMOLECULES, 2024, 14 (08)
  • [49] Allogeneic CAR-NK cells: A promising alternative to autologous CAR-T cells - State of the art, sources of NK cells, limits and perspectives
    Nguyen, Stephanie
    Lacan, Claire
    Roos-Weil, Damien
    BULLETIN DU CANCER, 2021, 108 (10) : S81 - S91
  • [50] Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
    Taheri, Mohadeseh Mohammad
    Javan, Fatemeh
    Poudineh, Mohadeseh
    Athari, Seyed Shamseddin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
12345